Study of ADI-PEG 20 Versus Placebo in Subjects With High Arginine Level and Unresectable Hepatocellular Carcinoma

Novel Treatment of Advanced Hepatocellular Carcinoma

NCT03950518 ·Status: UNKNOWN ·Phase: PHASE3

Adjuvant PD-1 Inhibitor for Patients With Early-stage Hepatocellular Carcinoma Following Microwave Ablation

NCT06248554 ·Status: RECRUITING ·Phase: NA

A Randomized Double-blind, Placebo-controlled Japanese Phase III Trial of ARQ 197 in Hepatocellular Carcinoma (HCC)

NCT02029157 ·Status: COMPLETED ·Phase: PHASE3

Treatment of Advanced Hepatocellular Carcinoma

NCT03278444 ·Status: UNKNOWN ·Phase: PHASE3

Immune Checkpoint Inhibitor Monotherapy or Combined With Molecular Targeted Drugs / Locoregional Therapy in the Treatment of Hepatocellular Carcinoma

NCT05609695 ·Status: UNKNOWN

Testing of ADI-PEG in Hepatocellular Carcinoma

NCT00056992 ·Status: COMPLETED ·Phase: PHASE2

Nivolumab and ADI-PEG 20 Before Surgery for the Treatment of Resectable Liver Cancer

NCT04965714 ·Status: WITHDRAWN ·Phase: PHASE2

A Trial of Hepatic Arterial Infusion Combined With Bevacizumab and Sintilimab for Unresectable A-staged Hepatocellular Carcinoma in BCLC Classification (D-TRIPLET)

NCT05214339 ·Status: UNKNOWN ·Phase: PHASE2

Anti-PD-1/PD-L1 Antibodies Plus Pegylated Interferon Alfa-2b Treatment in Patients With Advanced-Stage HCC

NCT04943679 ·Status: UNKNOWN

Anti-angiogenic Agents Plus Anti-PD-1 Antibodies for uHCC

NCT04639284 ·Status: UNKNOWN

Ablation Combined With PD-1 in HCC: Phase II Study

NCT04652440 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Study of Tivantinib in Subjects With Inoperable Hepatocellular Carcinoma (HCC) Who Have Been Treated With One Prior Therapy

NCT01755767 ·Status: COMPLETED ·Phase: PHASE3

Anti-angiogenesis Combined With PD-1/PD-L1 Therapy in Patients With Advanced Liver Cancer

NCT05383066 ·Status: UNKNOWN

Study of Pegylated Human Recombinant Arginase for Liver Cancer

NCT00988195 ·Status: COMPLETED ·Phase: PHASE1

Systemic Chemotherapy Plus Lenvatinib and Toripalimab for HCC With Extrahepatic Metastasis

NCT04170179 ·Status: UNKNOWN ·Phase: PHASE2

Anti-PD-1/PD-L1 Antibodies Plus Anti-VEGF Antibody Treatment in Patients With Advanced-Stage HCC

NCT06537908 ·Status: RECRUITING

Postoperative Antimicrobial Prophylaxis Versus Placebo for Infection Prevention in HCC After Liver Resection

NCT03990974 ·Status: SUSPENDED ·Phase: PHASE3

Adjuvant Therapy With Apatinib for HCC Patients With PVTT Who Underwent Radical Resection

NCT03261791 ·Status: UNKNOWN ·Phase: PHASE2

Study to Evaluate the Safety and Effectiveness of Microwave Ablation in Patients With Hepatocellular Carcinoma in Korea

NCT03586050 ·Status: COMPLETED ·Phase: NA

RT+ Anti-PD-1 for Patients With Advanced HCC (RT+PD-1-HCC)

NCT04193696 ·Status: UNKNOWN ·Phase: PHASE2

A Phase I, Open-label Study to Assess the Safety and Efficacy of Poly-ICLC Plus Nivolumab in Unresectable Hepatocellular Carcinoma Patients

NCT05281926 ·Status: UNKNOWN ·Phase: PHASE1

Evaluation of Hepatic Arterial Infusion of Cisplatin and 5-FU in Biomarker Stratified HCC

NCT02967887 ·Status: UNKNOWN ·Phase: PHASE2

A Randomized Phase II Trial of Surgery Plus Sorafenib vs. Sorafenib Alone for Hepatocellular Cancer (HCC) With Portal Vein Invasion

NCT03971201 ·Status: UNKNOWN ·Phase: PHASE2

Effects of Antiviral Therapy on Patients With HBV-related HCC

NCT05406089 ·Status: COMPLETED

Antiviral Therapy for Patients With Liver Cancer After Surgery

NCT05466565 ·Status: RECRUITING